Luye Pharma Completes Early Redemption of US$180.00 Million 6.25% Convertible Bonds

Bulletin Express07-06

Luye Pharma Group Ltd. announced the completion of the early redemption of all outstanding 6.25 per cent convertible bonds due 2028.

Key details: • Original issuance: US$180.00 million of 6.25 per cent convertible bonds, issued on 6 July 2023. • Bondholder option: Under Condition 8(E), investors could redeem their holdings at par plus accrued interest on 6 July 2026 (“Optional Put Date”). • Redemption size: Holders exercised the option for bonds totaling US$90.26 million in principal, representing 100 per cent of the outstanding amount. • Completion: As of 6 July 2026, Luye Pharma has fully redeemed and cancelled the bonds; no outstanding balance remains. • Listing status: The company has applied to The Stock Exchange of Hong Kong Limited to withdraw the bond listing, expected to take effect after market close on 15 July 2026.

The early redemption eliminates this tranche of debt from Luye Pharma’s balance sheet well ahead of the 2028 maturity, concluding the obligations associated with the instrument.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1141718858?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-06 21:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1141718858","market":"us","top_or_hot":-1,"title":"Luye Pharma Completes Early Redemption of US$180.00 Million 6.25% Convertible Bonds","media":"Bulletin Express","content":"<p>Luye Pharma Group Ltd. announced the completion of the early redemption of all outstanding 6.25 per cent convertible bonds due 2028.</p>\n<p>Key details:\n• Original issuance: US$180.00 million of 6.25 per cent convertible bonds, issued on 6 July 2023.  \n• Bondholder option: Under Condition 8(E), investors could redeem their holdings at par plus accrued interest on 6 July 2026 (“Optional Put Date”).  \n• Redemption size: Holders exercised the option for bonds totaling US$90.26 million in principal, representing 100 per cent of the outstanding amount.  \n• Completion: As of 6 July 2026, Luye Pharma has fully redeemed and cancelled the bonds; no outstanding balance remains.  \n• Listing status: The company has applied to The Stock Exchange of Hong Kong Limited to withdraw the bond listing, expected to take effect after market close on 15 July 2026.</p>\n<p>The early redemption eliminates this tranche of debt from Luye Pharma’s balance sheet well ahead of the 2028 maturity, concluding the obligations associated with the instrument.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Luye Pharma Completes Early Redemption of US$180.00 Million 6.25% Convertible Bonds</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLuye Pharma Completes Early Redemption of US$180.00 Million 6.25% Convertible Bonds\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-06 21:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Luye Pharma Group Ltd. announced the completion of the early redemption of all outstanding 6.25 per cent convertible bonds due 2028.</p>\n<p>Key details:\n• Original issuance: US$180.00 million of 6.25 per cent convertible bonds, issued on 6 July 2023.  \n• Bondholder option: Under Condition 8(E), investors could redeem their holdings at par plus accrued interest on 6 July 2026 (“Optional Put Date”).  \n• Redemption size: Holders exercised the option for bonds totaling US$90.26 million in principal, representing 100 per cent of the outstanding amount.  \n• Completion: As of 6 July 2026, Luye Pharma has fully redeemed and cancelled the bonds; no outstanding balance remains.  \n• Listing status: The company has applied to The Stock Exchange of Hong Kong Limited to withdraw the bond listing, expected to take effect after market close on 15 July 2026.</p>\n<p>The early redemption eliminates this tranche of debt from Luye Pharma’s balance sheet well ahead of the 2028 maturity, concluding the obligations associated with the instrument.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02186","symbol_name":"绿叶制药","start_time":0,"source_url":"","article_id":"1141718858","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1141718858","pubTimestamp":1783345342,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Luye Pharma Group Ltd. announced the completion of the early redemption of all outstanding 6.25 per cent convertible bonds due 2028. Key details: • Original issuance: US$180.00 million of 6.25 per...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02186":"绿叶制药"},"translate_title":"绿叶制药完成提前赎回1.80亿美元6.25%可换股债券","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02186":1},"content_text":"Luye Pharma Group Ltd. announced the completion of the early redemption of all outstanding 6.25 per cent convertible bonds due 2028.\nKey details:\n• Original issuance: US$180.00 million of 6.25 per cent convertible bonds, issued on 6 July 2023.  \n• Bondholder option: Under Condition 8(E), investors could redeem their holdings at par plus accrued interest on 6 July 2026 (“Optional Put Date”).  \n• Redemption size: Holders exercised the option for bonds totaling US$90.26 million in principal, representing 100 per cent of the outstanding amount.  \n• Completion: As of 6 July 2026, Luye Pharma has fully redeemed and cancelled the bonds; no outstanding balance remains.  \n• Listing status: The company has applied to The Stock Exchange of Hong Kong Limited to withdraw the bond listing, expected to take effect after market close on 15 July 2026.\nThe early redemption eliminates this tranche of debt from Luye Pharma’s balance sheet well ahead of the 2028 maturity, concluding the obligations associated with the instrument.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1141718858","isCrawlerRequest":true}